Uterine Cervical Neoplasms

• 

  Subject Areas on Research

  • "You just do your part. God will do the rest.": spirituality and culture in the medical encounter. 
  • 6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity. 
  • A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study. 
  • A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. 
  • A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. 
  • A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. 
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. 
  • A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. 
  • A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. 
  • A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. 
  • A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. 
  • A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients. 
  • A research for the relationship between human papillomavirus and human uterine cervical carcinoma. II. Molecular genetic and ultrastructural study on the transforming activity of recombinant retrovirus containing human papillomavirus type 16 subgenomic sequences. 
  • A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. 
  • Abnormal Fhit expression in malignant and premalignant lesions of the cervix. 
  • Abnormal outcomes following cervical cancer screening: event duration and health utility loss. 
  • Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. 
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. 
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. 
  • Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership. 
  • Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. 
  • Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. 
  • Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer. 
  • Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. 
  • Age-specific occurrence of HPV16- and HPV18-related cervical cancer. 
  • American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis. 
  • Analysis of results of radiation therapy for Stage II carcinoma of the cervix. 
  • Analysis of results of radiation therapy for stage IB carcinoma of the cervix. 
  • Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer? 
  • Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS. 
  • Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. 
  • Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer. 
  • Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. 
  • Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. 
  • Authors' reply: Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study: population and statistical queries. 
  • Awareness of Cervical Cancer Causes and Predeterminants of Likelihood to Screen Among Women in Haiti. 
  • Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. 
  • Barriers to Breast and Cervical Cancer Screening in Singapore: a Mixed Methods Analysis. 
  • Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey. 
  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. 
  • Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? 
  • Bilateral pelvic lymph node metastases in a case of FIGO stage IA(1) adenocarcinoma of the cervix. 
  • Blue nevus of the cervix. 
  • Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. 
  • CASP7 variants modify susceptibility to cervical cancer in Chinese women. 
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines. 
  • Can screening older patients for cancer save lives? 
  • Cancer control-planning and monitoring population-based systems. 
  • Cancer risk in women exposed to diethylstilbestrol in utero. 
  • Cancer screening behaviors and attitudes of women in southeastern Minnesota. 
  • Cancer screening practices among women in a community health center population. 
  • Carcinoma of the cervix, stage III. Results of radiation therapy. 
  • Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. 
  • Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. 
  • Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. 
  • Cardiac metastasis from carcinoma of the cervix: report of two cases. 
  • Cell cycle studies of cyclocreatine, a new anticancer agent. 
  • Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya. 
  • Cervical Cancer Screening. 
  • Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It? 
  • Cervical adenoid cystic carcinoma associated with ascites. 
  • Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. 
  • Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. 
  • Cervical cancer. 
  • Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. 
  • Cervical cytology screening. 
  • Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. 
  • Cervical intraepithelial neoplasia in HIV-infected women in a southeastern US population. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Changes in insurance coverage for cancer patients receiving brachytherapy before and after enactment of the Affordable Care Act. 
  • Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. 
  • Chapter 19: Cost-effectiveness of cervical cancer screening. 
  • Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol. 
  • Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. 
  • Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. 
  • Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Coital risk factors for cervical cancer. Sexual activity among white middle class women. 
  • Comparison of histologic and colposcopic findings in DES-exposed females. 
  • Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study. 
  • Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening. 
  • Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness of a potential vaccine for human papillomavirus. 
  • Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. 
  • Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. 
  • Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. 
  • Cystic fibrosis involving the cervix, mimicking a well-differentiated adenocarcinoma: a case report. 
  • Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. 
  • Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. 
  • DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions. 
  • DNA polymerase ζ as a potential biomarker of chemoradiation resistance and poor prognosis for cervical cancer. 
  • De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. 
  • Decision science and cervical cancer. 
  • Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under. 
  • Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening. 
  • Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings. 
  • Design of a plastic minicolpostat applicator with shields. 
  • Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. 
  • Disparities in Cervical Cancer Incidence and Mortality: Can Epigenetics Contribute to Eliminating Disparities? 
  • Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer? 
  • Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. 
  • Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. 
  • Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. 
  • Evaluating a stage model in predicting monolingual spanish-speaking Latinas' cervical cancer screening practices: the role of psychosocial and cultural predictors. 
  • Evaluating human papillomavirus vaccination programs. 
  • Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling. 
  • Evaluation of cervical cytology. 
  • Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. 
  • Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. 
  • Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader. 
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. 
  • FDG-PET for management of cervical and ovarian cancer. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya. 
  • Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology. 
  • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. 
  • Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. 
  • Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. 
  • GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. 
  • Genetic profiling to predict recurrence of early cervical cancer. 
  • Glassy cell carcinoma of the cervix. 
  • Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastasis from an appendiceal primary tumor through the use of cytokeratin-7 and -20 immunostains. 
  • Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. 
  • HIV Infection and Survival Among Women With Cervical Cancer. 
  • HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. 
  • HPV vaccines: now that they're here, how do we maximize their benefit? 
  • Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. 
  • Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. 
  • High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease. 
  • High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? 
  • Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. 
  • Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. 
  • Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program. 
  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. 
  • Human papillomavirus prevalence in a population of women living in Port-au-Prince and Leogane, Haiti. 
  • Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. 
  • Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. 
  • Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. 
  • Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? 
  • Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. 
  • Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 
  • Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening. 
  • Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. 
  • Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004. 
  • Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study. 
  • Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. 
  • Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007. 
  • Improving the sensitivity of cervical cytology: what are the issues? 
  • In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). 
  • Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. 
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. 
  • Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). 
  • Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. 
  • Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Incremental and average cost-effectiveness ratios: will physicians make a distinction? 
  • Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. 
  • Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act. 
  • Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. 
  • International Image Concordance Study to Compare a Point-of-Care Tampon Colposcope With a Standard-of-Care Colposcope. 
  • Intraoperative interstitial microwave-induced hyperthermia and brachytherapy. 
  • Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta. 
  • Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS). 
  • Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. 
  • Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. 
  • Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE). 
  • Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. 
  • Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. 
  • Major morbidity after pelvic exenteration: a seven-year experience. 
  • Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Men's knowledge and attitudes about cervical cancer screening in Kenya. 
  • Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies. 
  • Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. 
  • Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine. 
  • Minimally Invasive Lymphadenectomy in Uterine Cervical Cancer: A Systematic Review. 
  • Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution. 
  • Molecular characterization of adenocarcinoma of the cervix. 
  • Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5. 
  • Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. 
  • Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. 
  • Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. 
  • Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. 
  • Non-utilization of the Pap Test Among Women with Frequent Health System Contact. 
  • Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. 
  • Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny. 
  • Optical imaging of cervical pre-cancers with structured illumination: an integrated approach. 
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. 
  • Oral contraceptive use and risk of cancer--response. 
  • PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. 
  • Pain predicts non-adherence to pap smear screening among middle-aged African American women. 
  • Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). 
  • Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study. 
  • Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. 
  • Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. 
  • Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population. 
  • Pediatricians are more supportive of the human papillomavirus vaccine than the general public. 
  • Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro. 
  • Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. 
  • Perinatal Considerations in Women With Previous Diagnosis of Cancer. 
  • Peritoneal cytology and invasive carcinoma of the cervix. 
  • Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. 
  • Portable colposcopy in low-resource settings. 
  • Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. 
  • Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Predisease: when does it make sense? 
  • Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. 
  • Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. 
  • Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. 
  • Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. 
  • Prenatal diethylstilbestrol exposure and human genital tract abnormalities. 
  • Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population. 
  • Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya. 
  • Primary Health Care and Cervical Cancer Mortality Rates in Brazil: A Longitudinal Ecological Study. 
  • Primary care residents' characteristics and motives for providing differential medical treatment of cervical cancer screening. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. 
  • Psychometric validation and reliability analysis of a Spanish version of the patient satisfaction with cancer-related care measure: a patient navigation research program study. 
  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. 
  • Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. 
  • Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. 
  • RAD52 variants predict platinum resistance and prognosis of cervical cancer. 
  • Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes. 
  • Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. 
  • Radical hysterectomy in obese women. 
  • Rapid determination of oxygen saturation and vascularity for cancer detection. 
  • Recent developments in defining microinvasive and early invasive carcinoma of the uterine cervix. 
  • Relationship of epithelial ovarian cancer to other malignancies within families. 
  • Reproducibility of self-reported pap test utilization in middle-aged African-American women. 
  • Reproductive and maternal health in the post-2015 era: cervical cancer must be a priority. 
  • Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. 
  • Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. 
  • Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia. 
  • Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting. 
  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. 
  • Screening and early detection among racial and ethnic minority women. 
  • Screening for cervical cancer: a modeling study for the US Preventive Services Task Force. 
  • Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). 
  • Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. 
  • Selective screening for cervical neoplasia: an approach for resource-poor settings. 
  • Self reported morbidity and awareness regarding common cancers in elderly women. 
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. 
  • Short birth intervals and uterine cervical cancer risk in Jamaican women. 
  • Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. 
  • SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: data on 791 cases. 
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. 
  • Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol. 
  • Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. 
  • Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. 
  • Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. 
  • Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. 
  • Technologic advances for evaluation of cervical cytology: is newer better? 
  • The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. 
  • The LAST guidelines in clinical practice: implementing recommendations for p16 use. 
  • The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications. 
  • The clinical significance of blood transfusion at the time of radical hysterectomy. 
  • The current and future role of screening in the era of HPV vaccination. 
  • The economic impact of HPV vaccines: not just cervical cancer. 
  • The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts. 
  • The impact of health status on physicians' intentions to offer cancer screening to older women. 
  • The impact of human papillomavirus vaccination on cervical cancer prevention efforts. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. 
  • The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer. 
  • The influence of cost-effectiveness information on physicians' cancer screening recommendations. 
  • The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. 
  • The nucleolar localization domain of the catalytic subunit of human telomerase. 
  • The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The role of PET scanning in the detection of recurrent cervical cancer. 
  • The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network. 
  • The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. 
  • The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. 
  • Three-dimensional applicator system for carcinoma of the uterine cervix. 
  • Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. 
  • Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis. 
  • Treatment of late complications of ileal conduit. 
  • Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide. 
  • Tumoral calcium pyrophosphate dihydrate deposition disease mimicking a cervical spine neoplasm: case report. 
  • US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. 
  • Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. 
  • Utility scores and treatment preferences for clinical early-stage cervical cancer. 
  • Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Villoglandular adenocarcinoma of the cervix: a case report. 
  • Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Moorman, Patricia Gripka, Professor in Family Medicine and Community Health, Duke Cancer Institute
  • Palmer, Gregory M., Associate Professor of Radiation Oncology, Radiation Oncology